FBO#1053
A - Research and Development
AWARDS - October 14, 2004
- HHSN266200400031C - $2,362,639 with Option Period $2,146,168
DEVELOPMENT AND PRODUCTION OF AN INACTIVATED (2004) H5 INFLUENZA VACCINE FOR USE IN PHASE I/II CLINICIAL TRIALS
Aventis Pasteur Incorporated, Discovery Drive, Swiftwater, PA 18370
- HHSN266200400032C - $2,040,362 with Option Period $763,740
DEVELOPMENT AND PRODUCTION OF AN INACTIVATED (2004) H5 INFLUENZA VACCINE FOR USE IN PHASE I/II CLINICAL TRIALS
Chiron Corporation, 4560 Horton Street, Emeryville, CA 94608-2916
- N0001400G00580080 - $74,720.00
HYBRID SYSTEM CONCEPT DEVELOPMENT
The Pennsylvania State University, Office of Sponsored Programs, 110 Technology Center Building, University Park, PA 16802-7000
- HHSN266200400031C - $2,362,639 with Option Period $2,146,168
DEVELOPMENT AND PRODUCTION OF AN INACTIVATED (2004) H5 INFLUENZA VACCINE FOR USE IN PHASE I/II CLINICIAL TRIALS
Swiftwater, PA 18370
- HHSN266200400032C - $2,040,362 with Option Period $763,740
DEVELOPMENT AND PRODUCTION OF AN INACTIVATED (2004) H5 INFLUENZA VACCINE FOR USE IN PHASE I/II CLINICAL TRIALS
Emeryville, CA 94608-2916
| This Issue's Index | Today's FBO Daily Index Page |
Created on 12-Oct-2004 by Loren Data Corp. -- info@fbodaily.com